Crossmark

Initial reduction of the primary tumor or lymph nodes: which is the better prognostic factor in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemotherapy followed by surgery?

Crossref DOI link: https://doi.org/10.1007/s10388-025-01128-5

Published Online: 2025-04-28

Published Print: 2025-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hagi, Takaomi

Shiraishi, Osamu https://orcid.org/0000-0002-4740-5422
Terada, Masuhiro

Yamada, Atsushi

Kohda, Masashi

Nakanishi, Tomoya

Hiraki, Yoko

Kato, Hiroaki

Yasuda, Atsushi

Shinkai, Masayuki

Imano, Motohiro

Yasuda, Takushi
License Information

Text and Data Mining valid from 2025-04-28

Version of Record valid from 2025-04-28
More Information

Article History

Received: 11 November 2024

Accepted: 8 April 2025

First Online: 28 April 2025

Declarations

:

: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.

: The are no conflicts of interest.

: Informed consent or substitute for it was obtained from all patients for being included in the study.

Document is current

Any future updates will be listed below